FindTrial
Sign In

Dose-ranging study of OPC-41061 in patients with cardiac edema (congestive heart failure: CHF)

Dose-ranging study of OPC-41061 in patients with cardiac edema (congestive heart failure: CHF)

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220038
Enrollment
Unknown
Registered
2005-09-06
Start date
2005-09-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac edema (CHF)

Interventions

investigational material(s) Generic name etc : OPC-41061 INN of investigational material : Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational ma

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: CHF patients with edema, jugular venous distention, hepatomegaly, pulmonary congestion, or 3rd sound due to extracellular volume expansion despite taking oral furosemide, aged between 20 and 80 years, not inclusive, at time of consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy, safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026